VIAP Projected Dividend Yield
VIA Pharmaceuticals Inc ( OTCBB : VIAP )VIA Pharmaceuticals, Inc. is a biotechnology company focused on the treatment of cardiovascular and metabolic diseases. Co. is building a pipeline of small-molecule drugs that target cardiovascular and metabolic diseases. As of Dec 31 2010, Co.'s drug development pipeline included: VIA-3196, a liver-directed thyroid hormone receptor beta agonist, including high LDL cholesterol, high triglycerides and elevated Lp(a); a Diacylglycerol Acyl Transferase 1 inhibitor for diabetes, with upside potential in weight control and dyslipidemia; and its 5-LO inhibitor, VIA-2291, which targets the treatment of atherosclerotic plaque, a primary cause of heart attack, stroke and other vascular diseases. 20 YEAR PERFORMANCE RESULTS |
VIAP Dividend History Detail VIAP Dividend News VIAP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |